Loading…
The U.S. is seeking to further expand soybean sales to China despite strong existing growth in shipments. China's approval process for new biotech products is slow, and public opposition to GMOs remains strong.
A 100-day trade action plan includes a China review of eight pending U.S. biotech applications, two of them for soybean products.
Faster Chinese approval of GMO soybean traits would support export demand for U.S. beans, while continued delays keep a regulatory risk premium on the trade.
ecns.cnMay 17, 2017After 696 past bullish trade events, Soybeans moved a median +0.3% over 5 sessions (54% higher; middle half -1.3% to +1.9%), and +0.7% over 20.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
